Population-adjusted indirect comparison (PAIC) of avelumab (AVE) and retifanlimab (RETI) in the first-line (1L) treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC).

Authors

Laia M. Monfort (ORCID: https://orcid.org/0000-0002-7170-481X)
Karin Tyroller
Mairead Kearney
Hoora Moradian
Vikas Jangra

Institutions

Merck KGaA, Darmstadt (Germany) (DE)
Ono Pharmaceutical (United States) (US)

Publication Details

Journal: Journal of Clinical Oncology
Published: 2025-05-28
DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.e21513
Primary Topic: Polyomavirus and related diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Population-adjusted indirect comparison (PAIC) of avelumab (AVE) and retifanlimab (RETI) in the first-line (1L) treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC).

Laia M. Monfort, Karin Tyroller, Mairead Kearney, Hoora Moradian et al.

May 28, 2025

Journal of Clinical Oncology

Polyomavirus and related diseases

article

Population-adjusted indirect comparison (PAIC) of avelumab (AVE) and retifanlimab (RETI) in the first-line (1L) treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC).

Laia M. Monfort, Karin Tyroller, Mairead Kearney, Hoora Moradian, Vikas Jangra

May 28, 2025article en

Abstract

No abstract available for this paper.

Journal of Clinical OncologyVol. 43(16_suppl)

Merck KGaA, Darmstadt (Germany) (DE), Ono Pharmaceutical (United States) (US)

Openalex Percentile: Top 82%

Polyomavirus and related diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Population-adjusted indirect comparison (PAIC) of avelumab (AVE) and retifanlimab (RETI) in the first-line (1L) treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC). — Laia M. Monfort, Karin Tyroller, et al. · Journal of Clinical Oncology (2025) | TGRS Research Map | TGRS